Application no. and date | 17777119.3 (espacenet) (Federated) (European Patent Register), 20170913 | Patent/reg. no. and date | DK/EP 3432916, 20190814 | Publication date | 20190130 | Priority no. and date | US 201662394009 P, 20160913 | EP pub. no. and date |
EP 3432916 20190130 | Effective date | | Applicant/owner | Allergan, Inc., 2525 Dupont Drive
Irvine, California 92612, US | Applicant ref. no. | P70210DK01 | Inventor | ABIAD, Maurice, 3130 Olinda Lane
Anaheim, California 92804, US, DANI, Bhas, 4660 Terraza Mar Marvelosa
San Diego, California 92130, US, SHALAEV, Evgenyi, 33776 Bridge Hampton Drive
Dana Point, California92629, US | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 38/48 (2006.01) , A61K 47/02 (2006.01) , A61K 47/10 (2017.01) , A61K 47/18 (2017.01) , A61K 47/20 (2006.01) , A61K 47/26 (2006.01) , A61K 47/34 (2017.01) | Title | STABILISERET IKKE-PROTEIN CLOSTRIDTOXINSAMMENSÆTNINGER | Int. application no. | US2017051394 | Int. publication no. | WO2018053021 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|